RAC 1.11% $1.83 race oncology ltd

AML was our fastest pathway to approval - or at least it was 2...

  1. 2,664 Posts.
    lightbulb Created with Sketch. 3252
    AML was our fastest pathway to approval - or at least it was 2 years ago.

    The NPV of RAC would be far greater right now if there was revenue forecast for 2024. I think it was incorrectly designated a 'fall-back' option when it should have been licensed to advance and expedite all programs.

    Yes, the new formulation is a great opportunity, but we could have had FTO patient data from dozens of patients by now utilising central line administration.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.